Apricus Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch APRI and buy or sell other stocks, ETFs, and their options commission-free!About APRI
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders.
CEORaj Mehra, PhD, MBA
CEORaj Mehra, PhD, MBA
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1987
Founded1987
Employees—
Employees—
APRI Key Statistics
Market cap10.48M
Market cap10.48M
Price-Earnings ratio-0.08
Price-Earnings ratio-0.08
Dividend yield—
Dividend yield—
Average volume334.32K
Average volume334.32K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$49.80
52 Week high$49.80
52 Week low$0.94
52 Week low$0.94
Stock Snapshot
As of today, Apricus Biosciences(APRI) shares are valued at $0.85. The company's market cap stands at 10.48M, with a P/E ratio of -0.08.
Apricus Biosciences(APRI) stock opened on 2026-01-05 at —. The price climbed to — and dipped to —.
The Apricus Biosciences(APRI)'s current trading volume is 0, compared to an average daily volume of 334.32K.
In the last year, Apricus Biosciences(APRI) shares hit a 52-week high of $49.80 and a 52-week low of $0.94.
In the last year, Apricus Biosciences(APRI) shares hit a 52-week high of $49.80 and a 52-week low of $0.94.